41 – 50 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Screening for Prostate Cancer: Early Detection or Overdetection?
(
- Contribution to journal › Scientific review
-
Mark
Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
(
- Contribution to journal › Article
-
Mark
Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
(
- Contribution to journal › Article
-
Mark
Levels of Beta-Microseminoprotein in Blood and Risk of Prostate Cancer in Multiple Populations.
2012) In Journal of the National Cancer Institute(
- Contribution to journal › Article
-
Mark
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators : Results from the prostate biopsy collaborative group
(
- Contribution to journal › Article
-
Mark
Evaluating the PCPT risk calculator in ten international biopsy cohorts : Results from the Prostate Biopsy Collaborative Group
(
- Contribution to journal › Article
- 2011
-
Mark
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection
(
- Contribution to journal › Article
-
Mark
Tumor markers in prostate cancer I: Blood-based markers
(
- Contribution to journal › Scientific review
-
Mark
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
(
- Contribution to journal › Article